AbbVie Inc. · Brief

Next report

94 days

Feb 3 · before openest.Q4 FY26

Expected move

±10.6%implied · straddle

263.63326.15

spot 294.89exp Feb 19ATM strike 290ATM straddle 36.78IV 29%

Oct 30 closeprovisional

Expected move

8 reportsHistory

2 of 8≥ implied

Jan 31 '25±3.8%▲+4.70%×1.24

Apr 25 '25±4.1%▲+3.15%×0.77

Jul 31 '25±3.9%▼−0.15%×0.04

Q3 FY25±3.3%▼−4.45%×1.33

Feb 4 '26±3.9%▼−3.79%×0.96

Q1 FY26±4.0%▲+3.14%×0.78

Q2 FY26±3.5%▼−2.51%×0.72

Oct 30 '26±3.5%▲+1.41%×0.41

quarterimplied−5%0+5%realized×

Oct '26±3.5%▲+1.41%×0.41

Q2 FY26±3.5%▼−2.51%×0.72

Q1 FY26±4.0%▲+3.14%×0.78

Feb '26±3.9%▼−3.79%×0.96

Q3 FY25±3.3%▼−4.45%×1.33

Jul '25±3.9%▼−0.15%×0.04

2 older reports

Apr '25±4.1%▲+3.15%×0.77

Jan '25±3.8%▲+4.70%×1.24

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Feb 3 report · est.

—

ABBV report session

No linked exposure.

Oct 21impliedImplied move: ±4.1% into Oct 30 earnings (Oct 21 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.